An Adult And Adolescent Schizophrenia Study To Evaluate The Effects Of Extended Release Injectable
Posted Date: Jan 27, 2020
- Investigator: Caleb Adler
- Specialties: Adolescent Psychiatry/Psychology, Psychiatry/Psychology
- Type of Study: Drug
A Study to Evaluate the Safety, Tolerability, and Effect of Risperidone Extended-Release Injectable Suspension (TV-46000) for Subcutaneous Use as Maintenance Treatment in Adult and Adolescent Patients with Schizophrenia
Criteria:
Tv46000-Cns-30072 (Roll-Over Participant) Or A New Participant Who Did Not Participate In The Tv46000-Cns-30072 Study
Keywords:
Adult, Adolescent, Schizophrenia
For More Information:
Karen Tugrul, Bsn, Rn
513.558.6831
karen.tugrul@uc.edu